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Treatment of bovine mastitis with intramammary antibiotics is common, yet several concerns exist 
including failed efficacy for individual hosts or pathogens and the inability of approved drugs to revert 
mastitis-induced tissue damage to healthy tissue capable of returning to full milk production. These 
issues, in addition to aspects of public health such as accidental antibiotic residues in saleable milk 
and the potential for antimicrobial resistance, support the need to find alternative therapies for this 
costly disease. This study shows that the secretome, or collective factors, produced by mammosphere-
derived cells (MDC) promotes angiogenesis, epithelial cell migration, and contains proteins associated 
with immunity and defense; all of which are necessary for healing damaged mammary gland tissue. 
Furthermore, we found that the MDC secretome remains effective after freezing and thawing, 
enhancing its therapeutic potential. Our results provide a foundation for further characterization of 
the individual secreted factors and the rationale for using the MDC secretome as a complementary 
treatment for bovine mastitis.
Mastitis is defined as inflammation of the mammary gland, and the main etiological contributors in dairy animals 
are bacterial in origin. Clinical and subclinical mastitis, highly prevalent diseases in the dairy industry, have con-
siderable economic impacts with contributions to milk production losses, milk quality concerns, labor costs, and 
reproductive deficiencies1,2; each case, when occurring in early lactation, is estimated to cost approximately $4443. 
Gram-negative coliform bacteria acquired from the environment, such as Klebsiella (K.) pneumoniae, frequently 
cause an acute inflammatory response with severe clinical signs, while Gram-positive contagious pathogens such 
as Staphylococcus (S.) aureus may cause persistent, subclinical and chronic infections.
In addition to bacterial burden, damage caused to the mammary gland during mastitis reduces the num-
ber and activity of epithelial cells through disruption of alveolar cell integrity, sloughing of cells and induced 
apoptosis. This destruction will lead to a build-up of milk constituents in the secretory epithelium resulting in a 
breakdown of the basement membrane due to stromal thickening. This results in a decreased percentage of tissue 
areas occupied by alveolar epithelium and lumina and an increased percentage of interalveolar stromal areas4. 
The decrease in secretory epithelium consequently contributes to approximately 70% of the total cost of mastitis4.
The most common use for antibiotics on dairy farms is for the prevention of intramammary infections (IMI) 
and treatment of mastitis5. A survey performed by the USDA in 2014 showed that 21.7% of cows experiencing 
clinical mastitis are treated with antibiotics, and 96.9% of dairy facilities use antibiotics to treat clinical mastitis 
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cases6. Several advantages of antibiotic use for the treatment of mastitis have been reported and include faster 
clearance of bacteria, increased survival rate of cows, and reduction in losses of milk production7. However, 
the treatment of mastitis caused by coliform organisms such as K. pneumoniae with antibiotics alone is difficult 
because it is often characterized by massive inflammation and widespread udder tissue necrosis, primarily caused 
by the bacterial toxin lipopolysaccharide (LPS)8,9. As such, an important limitation of antibiotics is their inabil-
ity to fully revert the mastitis-induced epithelial structural damage in the udder to healthy pre-infection tissue 
capable of full milk production. Finally, use of antibiotics is directly related to the risk of residues in bulk tank 
milk, and the possible relationship of antimicrobial use to the emergence of resistance indicate reasons for public 
concern10.
Recent studies have shown that the cellular secretome, comprised of all secreted factors, plays an important 
role in various physiological processes, including cellular cross-talk and tissue regeneration11,12. The secretome of 
mesenchymal stem cells (MSC), a type of adult multipotent stem cells, is especially being studied in great depth 
due to its potential as a novel, stem cell-free, therapeutic strategy13,14. The MSC secretome contributes to healing 
processes by participating in the inflammatory, proliferative and remodeling phases of tissue repair, and can 
enhance bacterial clearance via the production of antimicrobial peptides (AMP)15,16. Based on these reported 
secretome properties and the need for alternative and/or adjunct therapies for mastitis, we decided to characterize 
the secretome of primary cells from the bovine mammary gland with an emphasis on potential regenerative and 
antimicrobial properties.
Results
Isolation of adherent fraction-derived cells (AFDC) and mammosphere-derived cells (MDC) 
from the bovine mammary gland yields two distinct populations. In order to study the secretome 
of bovine mammary cells, we isolated cells from fresh mammary tissue and cultured two different populations 
(Fig. S1). After enzymatic digestion, single cells were plated on a tissue culture dish for one hour. The population 
of adherent cells was collected and propagated as adherent fraction-derived cells (AFDC). The population of 
suspended cells was collected separately and propagated as mammospheres, a technique known to enrich for 
mammary stem/progenitor cells17,18. After an eleven-day selection period, these mammospheres were cultured 
on regular tissue culture plates and propagated as mammosphere-derived cells (MDC). AFDC and MDC were 
morphologically distinct from each other, with AFDC being morphologically heterogenic with some of the cells 
being epithelial-like while others displayed an elongated spindle-shaped morphology, and MDC being primarily 
epithelial-like with polygonal shapes that grew in discrete patches (Fig. S1).
We further characterized these two cell populations based on their expression of five mammary gland markers 
by immunofluorescence (IF). Vimentin, CK14 and alpha smooth muscle actin (αSMA) are markers of myoep-
ithelial cells19–22. Estrogen receptor alpha (ERα) and CK18 are markers of luminal epithelial cells21,23. Both cell 
populations expressed vimentin, while only AFDC expressed αSMA and CK14, and only MDC expressed ERα 
and CK18 (Fig. 1a). The IF was complemented with flow cytometry analysis to investigate the expression of 
three cell surface markers commonly used to immunophenotype mammary cells21,24,25. We found that CD29 was 
highly expressed on both cell types, but MDC expressed statistically more CD44 and CD49f compared to AFDC 
(Fig. 1b). Collectively, these results show that we isolated two distinct bovine cell populations with different 
morphology and, at least in part, a different protein expression pattern. Since mammospheres are known to be 
enriched in cells with stem/progenitor characteristics, as described above, we decided to determine the potential 
of the bovine MDC population to differentiate into milk-producing cells. To this end, cells were cultured on 
Matrigel in the presence of prolactin. Acinar structures could readily be detected after 14 days in culture (Fig. 1c) 
and these structures were positive for β-lactoglobulin using IF. These results show that the primary bovine MDC 
cultures, obtained through propagation as non-adherent mammospheres, indeed retain their potential to differ-
entiate into milk-secreting luminal epithelial cells in vitro.
Characterization of the secretomes from MDC and AFDC using mass spectrometry reveals 
secreted factors with antimicrobial and regenerative properties. Liquid chromatography-mass 
spectrometry was used to globally characterize the secretome, collected as conditioned medium (CM), from 
both MDC and AFDC. To this end, MDC and AFDC CM was submitted for proteomic analysis and yielded 
347 and 537 matched proteins from peptide sequences in MDC and AFDC CM, respectively. Table 1 lists the 
identified proteins related to defense and immunity and regeneration, such as angiogenesis and cell migration. 
Selected proteins from each category were then quantified using Western blot analyses or commercially available 
enzyme-linked immunosorbent assays (ELISAs).
For the defense and immunity category we selected lactoferrin (LTF) and cathelicidin (Cath), both of which 
have previously been described to act as antimicrobial peptides (AMP)26–29. Since commercially available ELISA 
were unable to detect these proteins within the given detection limit (data not shown), Western blot analyses were 
used. Both LTF and Cath were detected in the CM of both bovine cell populations (Fig. 2). Vascular endothelial 
growth factor a (VEGFa) and angiopoetin 1 (Ang-1) were selected from the angiogenesis category. Quantification 
by ELISA showed that the AFDC CM contained higher levels of VEGFa, whereas the MDC CM contained higher 
levels of Ang-1 (Table 2). Lastly, Transforming Growth Factor Beta (TGFβ), Insulin-like Growth Factor-1 (IGF-
1), and Hepatocyte Growth Factor (HGF) were selected from the migration category. Higher levels of TGFβ were 
detected by ELISA in MDC CM, whereas IGF-1 and HGF were equally expressed in both MDC and AFDC CM 
(Table 2).
Collectively, these results show that both MDC and AFDC secrete various factors with roles in immune 
defense and regeneration. Using a series of in vitro experiments, we subsequently determined whether these 
secreted factors also had functional consequences.
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MDC and AFDC CM protect epithelial cells from LPS-induced cell damage. An important con-
sequence of mastitis is epithelial cell damage caused by bacterial toxins. To determine if the secreted factors 
with roles in defense and immunity (Table 1) have a functional effect, we evaluated the effects of the MDC and 
AFDC CM on toxin-induced epithelial cell death. To this end, Madin-Darby Bovine Kidney Epithelial (MDBK) 
cells were treated with alpha-toxin (AT), a toxin produced by the Gram-positive Staphylococcus (S.) aureus, and 
lipopolysaccharide (LPS), a toxin produced by Gram-negative bacteria, such as Klebsiella (K.) pneumoniae, in 
the presence or absence of CM. As expected, both toxins (at concentrations of 10 and 50 mg/mL LPS and 1 and 
5 mg/mL AT) induced a significant reduction in epithelial cell viability relative to untreated cells, as measured by 
Figure 1. AFDC and MDC are distinct populations. (a) Immunofluorescence staining of AFDC and MDC, 
demonstrating expression of the mammary cell markers vimentin (expressed by both populations), αSMA, 
CK14 (expressed only in AFDC), ERα and CK18 (expressed only in MDC). Bars = 50 µm. (b) Flow cytometry 
was performed with three mammary cell surface markers: CD29, CD44 and CD49f. The percentage of positive 
cells was quantified compared to a relevant isotype control. (c) Immunofluorescence of acinar structures 
expressing β-lactoglobulin (green). Inset: enlargement of representative acinar structure. Nuclei were stained 
with DAPI (blue). Bar = 100 µm; *p < 0.05, ***p < 0.001.
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a reduction in cell metabolism (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTT assay) and 
an increase in lactate dehydrogenase (LDH) release (Fig. 3a & b). No protective effect of the CM from both MDC 
and AFDC was observed in AT-treated cells (Fig. 3a). In contrast, a protective effect on cell viability was observed 
for the CM from either cell types on LPS-treated epithelial cells for cells treated with 50 mg/ml LPS (Fig. 3b). The 
combination of these findings, in addition to the observed presence of AMPs in the secretome, encouraged our 
group to consider the direct effects of CM on Gram-negative bacteria. To this end, we cultured the Gram-negative 
coliform mastitis pathogen K. pneumoniae in the presence or absence of MDC and AFDC CM. We measured 
bacterial growth as optical density (OD) and colony forming unit (CFU) counts, which we determined to have a 
correlation at log-phase growth of 0.95. Compared to bacteria grown in the absence of CM (control), a statistical 
reduction in OD was observed for bacteria grown in MDC, but not AFDC, CM, indicating an effect of the MDC 
CM on the growth of K. pneumoniae (Fig. 3c). However, as no differences in CFU counts were observed between 
bacteria grown in the presence of MDC CM and non-CM cultured bacteria (Fig. 3d), these effects are most likely 
bacteriostatic in nature, rather than bacteriocidal. As expected, no reduction in CFU was observed when bacteria 
were grown in AFDC CM (Fig. 3d).
MDC CM stimulates angiogenesis not by proliferation, but by the promotion of bovine 
endothelial tube formation. Because we identified VEGFa and Ang-1 in the CM of MDC and AFDC, 
we evaluated the effects of the secretome on blood vessel formation. New blood vessels allow for a better supply 
of oxygen and nutrients to the damaged tissue, and as such, angiogenesis is an important aspect of the tissue 
repair process after damage30. First, we confirmed the presence of Fms related tyrosine kinase 1 (FLT1) and TEK 
receptor tyrosine kinase (TEK), the receptors for VEGFa and Ang-1, respectively, in bovine lung microvessel 
endothelial cells (BLMVEC) (Fig. 4a). Next, we used a bromodeoxyuridine (BrdU) proliferation assay to deter-
mine the effects of MDC and AFDC CM on BLMVEC proliferation. No difference was observed in proliferation 
between BLMVEC cultured in the presence or absence of CM (Fig. 4b). In contrast, when a luciferase-based assay 
was used to evaluate endothelial tube formation in the presence of MDC CM, AFDC CM, and non-conditioned 
Dulbecco’s Modified Eagle’s medium (DMEM), there was an increase in mean tube length in endothelial cells 
MDC AFDC
Proteins having a role in defense and immunity
Alpha-2-macroglobulin Alpha-2-macroglobulin
Cathepsin Cathepsin
Alpha-1B-glycoprotein Alpha-1B-glycoprotein
Pantetheinase Pantetheinase
Beta-2-microglobulin Beta-2-microglobulin
Protein S100-A11 Protein S100-A11
Mannose-binding protein C Mannose-binding protein C
Lactoferrin Lactoferrin
Peptidoglycan recognition protein Collectin-43
Cathelicidin-7 Cathelicidin-1
Contactin-1 Contactin-1
Collectin-11 Collectin-11
Zinc-alpha-2-glycoprotein Zinc-alpha-2-glycoprotein
Phospholipid transfer protein
Interleukin-6 receptor subunit beta
Hepatitis A virus cellular receptor 1
Proteins having a role in angiogenesis
Angiopoitin-related protein 3 precursor Angiopoitin-related protein 3 precursor
Vascular endothelial growth factor A isoform 4 precusor
Proteins having a role in cell migration
Hepatocyte growth factor activator preproprotein Hepatocyte growth factor activator preproprotein
Hepatocyte growth factor-like protein isoform X1 Hepatocyte growth factor-like protein isoform X1
Hepatocyte growth factor receptor precursor Insulin-like growth factor binding protein 4 precursor
Insulin-like growth factor binding protein 2 precursor Insulin-like growth factor binding protein 2 precursor
Insulin-like growth factor binding protein 6 precursor Insulin-like growth factor binding protein 6 precursor
Insulin like growth factor isoform X1 Insulin like growth factor isoform X1
Insulin-like growth factor binding protein complex acid labile 
subunit precursor
Insulin-like growth factor binding protein complex acid labile 
subunit precursor
Transforming growth factor beta induced protein ig-h3 precursor Transforming growth factor beta induced protein ig-h3 precursor
Fibroblast growth factor binding protein 1 precursor Transforming growth factor beta-2 isoform X1
Table 1. Proteins identified in the conditioned medium (CM) of bovine mammosphere-derived cells (MDC) 
and adherent fraction-derived cells (AFDC) by mass spectrometry.
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cultured in MDC CM compared to endothelial cells cultured in DMEM. A numerical increase was seen for cells 
cultured in AFDC CM, but statistical differences were not observed. (Fig. 4ci & ii). Total tube length as well as the 
number of tubes, were not altered in the presence of CM (Fig. 4ciii & iv).
MDC CM increases bovine epithelial cell migration. The final functional experiments performed 
assessed epithelial cell migration, as proteins with a role in cell migration were described in the mass spectrom-
etry analysis (Table 1) and confirmed with ELISA (Table 2). As with proteins involved in angiogenesis, we first 
confirmed the presence of receptors on MDBK cells for the 3 proteins identified by ELISA, namely TGFβ receptor 
(TGFBR) for TGFβ, IGF-1 receptor (IGFR) for IGF-1, and MET proto-oncogene receptor tyrosine kinase (MET) 
for HGF using RT-PCR (Fig. 5a). In vitro scratch assays were used to evaluate the potential of MDC and AFDC 
CM to promote epithelial cell migration, and we found that MDBK cells migrated faster in the presence of MDC, 
but not AFDC, CM when compared to epithelial cells in DMEM (Fig. 5bi & ii). This effect was independent of 
cell proliferation, as we did not find an increase in the proliferation of epithelial cells when cultured in CM from 
either MDC or AFDC (Fig. 5c). To follow up on the increased rate of migration observed with the MDC CM, we 
repeated the scratch assays in the presence of commercially available recombinants of TGFβ, IGF-1, and HGF, 
alone or in combination. Given the statistical differences between each individual recombinant protein and the 
DMEM control, as well as between the combination of proteins and the DMEM control, it is likely that these 
proteins are contributing to the differences in migration rate that we observe when cells are treated with MDC 
CM (Fig. 5d). To further evaluate this, we treated the MDC CM with neutralizing antibodies for each protein, 
alone or in combination, and repeated the scratch assay. We observed a reduced migration in the presence of 
antibodies against HGF alone and the combination of all 3 antibodies, although this did not reach significance 
(Fig. 5e). Collectively, these results indicate that HGF, alone or in combination with TGFβ and IGF-1, at least in 
part contributes to cell migration.
Figure 2. MDC and AFDC secrete antimicrobial peptides (AMP). (a) Representative images of protein lysates 
run on polyacrylamide gels, transferred to PVDF membranes, and probed with anti-AMP antibodies. 40 μg of 
each sample was loaded per lane. Lane 1 = MDC CM; Lane 2 = AFDC CM. (b) Band densities of two AMPs in 
MDC and AFDC CM as detected by western blot. *p < 0.05.
Protein Abbreviation MaSC BMF P-value
Angiogenesis
Vascular endothelial growth factor a VEGFa 312 ± 15 pg/ml 568 ± 47 pg/ml 0.004
Angiopoitin 1 Ang-1 6150 ± 685 pg/ml 3629 ± 821 pg/ml 0.017
Migration
Transforming growth factor beta TGFβ 1916 ± 611 pg/ml 460 ± 343 pg/ml 0.02
Insulin-like growth factor 1 IGF-1 82 ± 16 pg/ml 64 ± 2 pg/ml 0.156
Hepatocyte growth factor HGF 57 ± 49 pg/ml 19 ± 17 pg/ml 0.309
Table 2. Quantification of secreted factors in bovine mammosphere-derived cells (MDC) and adherent 
fraction-derived cells (AFDC) using sandwich ELISA. Values represent the average ± standard deviation of 
three biological replicates. *NA: not applicable.
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Changes in the physiological environment of cells are known to alter the secretome31. For this reason, we 
decided to explore whether pretreating bovine MDC with stimulating agents would enhance the observed posi-
tive effect of their secretome on migration. To this end, we pre-stimulated MDC with xanthosine (Xan), Uridine 
Figure 3. MDC and AFDC CM prevent epithelial cell damage from LPS but not alpha toxin. Madin-Darby 
Bovine Kidney Epithelial (MDBK) cells were treated with two different concentrations of alpha toxin (AT) (a) 
or lipopolysaccharides (LPS) (b) with or without MDC or AFDC CM. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; i) and LDH (lactate dehydrogenase) release assays (ii) were used to determine 
viability. (c) Inhibitory effect of 50% MDC CM and AFDC CM on K. pneumoniae as a percentage of the 
positive control (CM-free DMEM) indicated by the dashed line; growth was measured after an 8 h incubation 
(37 °C) as optical density at 600 nm in a 96-well plate (* indicates MDC being significantly different from 
control at P < 0.05). (d) Inhibitory effect was not present when growth was measured as a colony forming unit 
(CFU) count on LB agar after serial dilution and overnight incubation (16 h; 37 °C) of wells in (C). *p < 0.05, 
**p < 0.01, ***p < 0.001.
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triphosphatase (UTP), or Salvionolic acid B (SalB), alone or in combination, and collected the CM from these 
stimulated MDC for use in scratch assays. Xanthosine is a nucleoside analogue previously used to enhance bovine 
mammary stem/progenitor cells in vitro and in vivo32,33. UTP is also a natural nucleoside analogue, known to 
stimulate hematopoietic stem cells, and SalB is an antioxidant known to stimulate adult neural stem/progenitor 
cells34,35. Unfortunately, none of the MDC CM from individual pretreatments nor the combination of treatments, 
resulted in an increased migration rate of bovine epithelial cells when compared to the migration rate observed 
with unstimulated MDC CM (Fig. 5f).
While the culture of MDC is not technically challenging, the generation of CM does take several days. Storing 
CM long term for off-the-shelf use would be advantageous for treatment. As the effects of MDC CM were most 
pronounced on MDBK migration, we used this assay to test the efficacy of MDC CM after freezing at −80 °C for 
one week. We found that we can freeze the MDC CM without loss of activity on cell migration (Fig. 5g), which 
has important consequences for future clinical use in mastitis management.
Figure 4. MDC CM stimulates endothelial tube-like formation in vitro. (a) Reverse transcription-polymerase 
chain reaction (RT-PCR) was used to evaluate the expression of the FLT-1 (Angiopoietin-1 receptor) and TEK 
(Vascular Endothelial Growth Factor a receptor) in BLMVEC. RT-PCR products were run on a 1% agarose gel. 
(b) A bromodeoxyuridine (BrdU) proliferation assay was performed to evaluate the proliferation activity of 
BLMVEC after incubation with MDC or AFDC CM. BrdU incorporation was measured by determining the 
optical density at 450 nm on a Multiskan EX microplate reader using Ascent software (ThermoFisher Scientific). 
(c) BLMVEC were seeded on an extracellular matrix gel in the presence or absence of MDC or AFDC CM to 
evaluate the tube-like formation capacity in vitro. After 18 h of culture, BLMVEC were stained with 10 μl of 
10X cell-based calcein. JNJ inhibitor was used as a negative control. Fluorescent and brightfield photographs 
were taken using a ZOE Fluorescent Cell Imager (BioRad). Representative images are shown (i). Images were 
quantified by Wim Tube Solutions for mean tube length (ii), total tube length (iii) and the number of tubes (iv). 
*p < 0.05.
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Discussion
This study characterized the secretome of bovine primary adherent fraction-derived cells (AFDC) and 
mammosphere-derived cells (MDC), and subsequently demonstrated the functionality of secreted factors 
involved in bacterial inhibition, angiogenesis and epithelial cell migration. As such, this study provides in vitro 
evidence of the therapeutic potential of primary bovine mammary cell conditioned medium (CM) in mastitis 
management.
Liquid chromatography-mass spectrometry identified several classes of antimicrobial peptides (AMP) secreted 
by MDC and AFDC. This is in line with previous studies from our lab and others, where the secretome of mesen-
chymal stem cells (MSC), a type of adult stem cell, was found to contain AMP and was able to inhibit the growth of 
bacteria15,16,36. In contrast to MSC CM, however, MDC CM had only a weak direct effect on bacterial growth and 
AFDC CM had no effect, at least for Klebsiella (K.) pneumoniae. Because the bacterial toxin lipopolysaccharide 
(LPS) produced by this bacterium is primarily responsible for the severe inflammation and sequelae of clinical 
signs and marked decreases in milk production8,9, we evaluated whether the secretome of MDC and AFDC could 
protect against LPS-induced epithelial damage. Our results showed that the CM from MDC and AFDC could pro-
tect bovine epithelial cells from LPS-induced damage. As previous studies have shown that the human cathelicidin 
cleavage product LL-37 can interfere directly with LPS37, and we did detect bovine cathelicidin in the secretome, we 
hypothesize that this AMP and/or its cleavage product myeloid antimicrobial peptide-27 (BMAP-27), the bovine 
homologue of human LL-37, is responsible for the observed protection against LPS-induced damage.
Figure 5. MDC CM stimulates epithelial cell migration but not proliferation. (a) RT-PCR was used to evaluate 
whether MDBK cells express receptors TGFBR (transforming growth factor beta receptor), IGFR (insulin-like 
growth factor receptor), and MET (hepatocyte growth factor receptor) for the migratory factors detected in 
the MDC and AFDC CM. RT-PCR products were run on a 1% agarose gel. (b) A scratch was made through a 
confluent layer of MDBK cells that were cultured with or without MDC or AFDC CM. Quantification of the 
rate of migration of MDBK cells incubated with MDC or AFDC CM using ImageJ software (i). Representative 
images of migration assays (ii). (c) A BrdU proliferation assay was performed to evaluate the proliferation 
activity of MDBK cells after incubation with MDC or AFDC CM. (d) Quantification of the rate of migration 
of MDBK cells cultured with or without MDC CM in the presence of TGFβ, IGF-1, HGF, or all (combined) 
recombinant proteins. (e) Quantification of the rate of migration of MDBK cells cultured with or without MDC 
CM in the presence of neutralizing antibodies for TGFβ, IGF-1, HGF, or all (combined). (f) Quantification of 
the rate of migration of MDBK cells cultured with CM from MDC treated with uridine triphosphate (UTP), 
salvionolic acid B (SalB), xanthosine (Xan), or all three (combo). Measurements are relative to untreated MDC 
CM indicated by the dotted line. (g) Quantification of the rate of migration of MDBK cells cultured with CM 
from MDC collected fresh (fresh CM) or frozen at −80 °C for one week and thawed (frozen CM). *p < 0.05. 
Different letters indicate statistically significant (p < 0.05) differences. Bar = 100 µm.
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Besides AMPs, we also identified other secreted factors, more specifically those involved in angiogenesis and 
cell migration. For the latter, we decided to follow up on transforming growth factor beta (TGFβ), insulin-like 
growth factor 1 (IGF-1), and hepatocyte growth factor (HGF), based on their effects on epithelial cell survival 
and/or mitogenic action on epithelial cells38–41. Specifically, we treated epithelial cells with recombinant proteins 
of TGFβ, IGF-1, and HGF, and found a stimulating effect on migration when compared to epithelial cells cultured 
in complete MDC CM. However, the level of stimulation could only match the level of stimulation with the CM 
when all three recombinants were given simultaneously, highlighting one of the advantages of using whole CM 
over a treatment strategy using individual proteins. Additionally, inhibiting the activity of these proteins in MDC 
CM by pre-incubating the CM with neutralizing antibodies against TGFβ, IGF-1, and HGF, alone or in combi-
nation, only modestly reduced migration, indicating that other proteins contribute to this effect. The presence 
of various bioactive factors in the secretome with various effects on host defense and immunity, angiogenesis, 
and/or cell migration, further support the use of CM in its entirety as these factors act in concert to promote 
regeneration.
The natural nucleoside analogue xanthosine (Xan) has been shown to increase stem cell proliferation in vitro 
and to increase the number of stem cells in the mammary gland of heifers in vivo32,33. However, no information 
is available on the potential effect of Xan, and other nucleoside analogues such as uridine triphosphate (UTP) 
or the antioxidant salvionolic acid B (SalB), all used previously to stimulate stem cells34,35, on the composition of 
bioactive factors in the stem cell secretome. To test this, we pre-treated bovine MDC with these compounds, using 
similar concentrations as reported in the literature, and used their CM in in vitro scratch assays. When compared 
to the CM collected from MDC that were not pre-treated, no significant differences in migration rates were 
observed. Several reasons could explain the lack of increased migratory activity of the CM from these pre-treated 
cells. For example, the effect of the stimulant may have been short and transient and, therefore, no longer present 
24 hours after changing the media, when CM was collected for experiments. Another explanation could simply 
be that an increase in cell proliferation does not correlate with an increased secretory capacity of factors involved 
in cell migration and/or was insufficient to be translated into a functional effect. Transcriptional analyses of 
MDC stimulated with these compounds would provide useful information about which genes are upregulated. 
Genes involved in migration and other functions could subsequently be quantified on a protein level in the MDC 
secretome and studied in more detail. In contrast, we were able to demonstrate that freezing and thawing of 
the MDC CM did not adversely affect the migration stimulation when compared to fresh CM. Based on these 
results, one could anticipate that the CM of MDC can be formulated as a readily available, shelf-stable, biological 
product to be used in intramammary preparation. The use of CM, in general, negates the risk of rejection when 
using the cells themselves as a therapeutic42. Still, future research is needed to confirm the beneficial effects of 
the MDC secretome in vivo, particularly with regards to the effects of competing in vivo factors, such as immune 
cells and the presence of milk proteins, on the efficacy of the CM. Moreover, the duration of efficacy of the CM 
will be important to evaluate, as the half-live of many growth factors, such as those found in this study, tends to 
be short43.
Taken together, our study provides the rationale for the potential use of the MDC secretome as an adjunct 
therapy in mastitis management. The functionality of secreted proteins, combined with the ease and low cost 
of isolating and culturing bovine MDC, makes the secretome an ideal biological source for naturally-occurring 
peptides as well as other bioactive factors.
Materials and Methods
Cells. Bovine primary mammary adherent fraction-derived cells (AFDC) and mammosphere-derived cells 
(MDC) were isolated as follows. Mammary gland tissues from clinically healthy, non-lactating heifers were col-
lected after euthanasia by excising 2 parts of 5 cm2 of tissue next to the median line of the two mammary gland 
compartments. Samples were dissociated mechanically with a sterile scalpel, followed by enzymatic digestion 
with 0.1% collagenase III (Worthington Biochemical Corporation, Lakewood, NJ) at 37 °C for 60 min. The cell 
suspension was subsequently filtered through sterile 100 and 40 μm filters to obtain a single cell suspension, 
and centrifuged at 400 × g for 10 min at room temperature (RT). Cells were resuspended in phosphate buffered 
saline (PBS) with 1% penicillin-streptomycin (P/S), centrifuged at 260 × g for 10 min, and resuspended in MDC 
medium, consisting of Dulbecco’s modified Eagle’s medium (DMEM)/F12 (50/50) supplemented with 10% fetal 
bovine serum (FBS), 2% B27 (all from Invitrogen, Carlsbad, CA), 1% penicillin/streptomycin (P/S), 10 ng/mL 
basic-fibroblast growth factor (BioVision, Milpitas, CA), and 10 ng/mL epidermal growth factor (Sigma-Aldrich, 
St. Louis, MO). Approximately 1 × 106 cells were seeded on a 6-well tissue culture dish for 1 h and this was 
repeated once more. The adherent cells were further propagated as AFDC. The non-adherent cells were collected 
and seeded at approximately 20,000 cells/cm2 on 6-well ultralow attachment plates (Elscolab, Corning, NY). 
MDC medium was refreshed twice a week by means of centrifugation of the mammospheres at 300 × g for 7 min. 
For further experiments, mammospheres were seeded on adhesive tissue culture dishes in MDC medium unless 
where indicated otherwise. The bovine cell lines Madin-Darby bovine kidney epithelial (MDBK) and bovine 
lung microvessel endothelial cells (BLMVEC) were cultured in DMEM supplemented with 10% FBS (Atlanta 
Biologicals, Lawrenceville, GA) and 1% P/S. All cell lines were maintained at 37 °C in a humidified environment 
with 5% CO2.
Immunostaining. Fixed cultures were incubated overnight at 4 °C with primary antibodies diluted in 
PBS, then washed and incubated for 1 hour at room temperature with a fluorescently labeled secondary anti-
body. Primary antibodies used included mouse monoclonal RV202 anti-vimentin, mouse monoclonal LL002 
anti-CK14 (Abcam, Cambridge, MA), mouse monoclonal 1A4 anti-alpha smooth muscle actin (Dako, Santa 
Clara, CA), mouse monoclonal TE111.5D11 anti-estrogen receptor alpha, mouse monoclonal C-04 anti-CK18 
(ThermoFisher Scientific, Waltham, MA), and rabbit polyclonal anti-β-lactoglobulin (diluted 1:100; Abcam). 
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Secondary antibodies used included Alexa Fluor 488-Goat Anti-Mouse IgG or Alexa Fluor 488-Goat Anti-Rabbit 
IgG (both diluted 1:250, Jackson ImmunoResearch, West Grove, PA). DAPI was used to stain nuclei. Stained 
cultures on coverslips were mounted on glass slides and visualized using a confocal laser scanning microscope 
(Zeiss, Oberkochen, Germany). β-lactoglobulin-stained acini were visualized in a ZOE Fluorescent Cell Imager 
(BioRad, Hercules CA).
Flow cytometric analyses. Cells were collected using accutase (Innovative Cell Technologies, San Diego, 
CA) and stained with mouse monoclonal TDM29 anti-CD29 (diluted 1:50; Sigma-Aldrich), rat monoclonal 
IM7 anti-CD44 (diluted 1:20; ThermoFisher Scientific), or rat monoclonal GoH3 anti-CD49f (diluted 1:10; 
BD Biosciences, San Jose, CA) antibodies diluted in PBS with 1% BSA, for 1 h. Staining with an isotype con-
trol antibody (Abcam), diluted 1:10 in PBS with 1% BSA, or no antibody stain were included as controls. Cells 
were washed three times in PBS and incubated with Alexa 488-conjugated secondary goat anti-rabbit and goat 
anti-mouse antibodies diluted 1:500 in PBS with 1% BSA, for 30 min. After washing, 50,000 cells were analyzed 
on a Gallios flow cytometer controlled by Kaluza for Gallios software (Beckman Coulter, USA). Data analysis was 
conducted using Kaluza Analysis software (Beckman Coulter).
Acinar differentiation assays. Acinar differentiation assay followed the methods of Dontu et al. (2003), 
with slight modification17. Bovine MDC were seeded on wells pre-coated with Matrigel (Corning), at a density of 
53 cells/cm2 (100 cells/well in a 24-well plate) and cultured in MDC medium. After 7 days, a layer of Matrigel was 
added in addition to fresh medium containing prolactin (Sigma-Aldrich) at 1 µg/mL. Seven days later, 3D acinar 
structures were fixed in situ, stained for β-lactoglobulin, and imaged with the ZOE Fluorescent Cell Imager (as 
described above).
Generation of conditioned medium (CM) and Pretreatments. CM was collected from MDC and 
AFDC after 2 days of culture, when cells were 70% confluent. To this end, 1 × 106 cells were seeded in a T75 flask 
in 10 mL of DMEM + 10% FBS + 1% P/S. After 24 h, cells were washed twice with PBS and medium was changed 
to DMEM without serum or antibiotics. Twenty-four hours later, the supernatant was collected and, after centrif-
ugation twice for 10 min at 400 × g, used for additional experimentation.
For the pre-treatment experiments, MDC were seeded in MDC medium supplemented with 200 µM xantho-
sine (Xan), 10 µM uridine triphosphatase (UTP), or 50 µM salvionolic acid B (Sal B), all from Sigma-Aldrich. 
After 24 h of culturing, the cells were washed twice with PBS and medium was changed to DMEM without serum 
or antibiotics. CM was collected 24 h later as described.
Mass Spectrometry (MS). In-solution digestion was performed following a protocol by Zhang et al. (2003) 
with slight modification44. The protein pellet from 10 mL of medium culture was dissolved in 300 µL denaturing 
solution containing 6.0 M guanidine-hydrochloride, and 100 mM PBS pH 7.0, sonicated for 5 min, centrifuged, 
and supernatant was collected. The denatured sample was reduced with 10 mM dithiothreitol and alkylated with 
55 mM iodoacetamide for 1 h at RT. Excess iodoacetamide was quenched with 30 mM dithiothreitol for 30 min 
at RT. The samples were diluted to a final volume of 3,775 µL with 50 mM Tris hydrochloride pH 8.0 to reduce 
the guanidine-hydrochloride concentration to less than 1 M. The samples were digested by adding 25 µg trypsin 
(Promega, Madison, WI) and incubated at 37 °C for 16 h. Digestions were stopped by the addition of 25 µL trif-
luoroacetic acid. The digests were further desalted by solid phase extraction using Sep-Pack Cartridge (Waters 
Corporation, Milford, MA) and the eluted peptides were evaporated to dryness by a Speedvac SC110 (Thermo 
Savant, Milford, MA). The data-dependent acquisition raw files for collision-induced dissociation tandem mass 
spectrometry only were subjected to database searches using Proteome Discoverer 2.2 software (ThermoFisher 
Scientific) with the Sequest HT algorithm.
Western Blot analyses. CM was collected, as described above, and incubated with a 1X general pro-
tease inhibitor. Protein concentration was determined with a bicinchoninic acid protein assay (ThermoFisher 
Scientific) prior to gel loading to ensure loading of an equal amount of protein (40 μg). 6X reducing sample 
buffer was added to yield a final concentration of 1X and lysates were boiled for 10 min at 95 °C. Samples were 
subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis on a 12% gel and transferred to immo-
bilin polyvinylidine difluoride membranes (Millipore, Billerica, MA) using a transblot turbo system (Biorad). 
Membranes were blocked in 5% BSA diluted in Tris buffered saline (TBS) and incubated with lactoferrin (LTF) 
antibodies diluted 1:50 or bovine cathelicidin (Cath) antibodies diluted 1:1000 in TBS + 5% BSA for 1 h at RT on 
a rotating platform. Blots were washed for 50 min (10 × 5 min) with TBS-Tween, then incubated with a 1:20,000 
dilution of HRP-conjugated goat anti-rabbit or HRP-conjugated goat anti-mouse antibodies for 1 h at RT. All blots 
were washed for 50 min (10 × 5 min) with TBS-Tween and then visualized by chemiluminescence using Clarity 
Western ECL (BioRad). Gels were imaged on a BioRad ChemiDoc MP system (BioRad) and band intensities were 
determined using Image Lab software.
Enzyme-Linked Immunosorbent Assays (ELISA). The concentration of VEGF, ANG-1, TGFβ, IGF-1, 
and HGF in CM was determined in duplicate wells by sandwich ELISA, following the manufacturer’s guidelines 
for each kit (VEGF: Sigma-Aldrich; ANG-1, TGFβ, IGF-1, HGF: LifeSpan BioSciences, Inc., WA).
Gene expression analysis. Cells were seeded at a density of 2 × 105 in T25 tissue culture flasks. After 48 h, 
mRNA was extracted from the cells using an RNEasy Plus Kit (QIAGEN, Valencia CA) and cDNA was synthe-
sized using M-MLV Reverse Transcriptase (USB, Cleveland, OH), both according to manufacturer’s protocols. 
The amplification reactions were performed using Invitrogen reagents (Life Technologies, Grand Island, NY) and 
www.nature.com/scientificreports/
1 1SCIeNtIfIC REPORTS |  (2018) 8:5378  | DOI:10.1038/s41598-018-23770-z
an Eppendorf Mastercycler. Following standard gel electrophoresis, products were visualized using a ChemiDoc 
MP Imaging System (Bio-Rad, Hercules, CA). Primers to amplify FLT-1, TEK, TGFβR, MET and IGF-1R were 
designed using Primer3 software, based on bovine sequences found in the National Center of Biotechnology 
Information (NCBI) GenBank. Primer sequences are listed in Table 3.
Bacteria. All bacteria were acquired from the Quality Milk Production Services (QMPS) at Cornell 
University, Ithaca, NY and were kept as frozen stocks in glycerol. One isolate of the known mastitis-causing field 
strain of Klebsiella pneumoniae was acquired from a NYS dairy farm. Bacteria were streaked on trypticase soy 
agar containing 5% sheep blood and 1% esculin (PML Microbiologicals, Canada) and incubated for 24 h at 37 °C 
for the isolation of single colonies prior to the start of experiments. A selected colony was inoculated and grown 
for 16–18 h overnight in 5 mL Luria-Bertani (LB) broth (ThermoFisher Scientific) with constant shaking at 37 °C. 
Antibacterial activity was measured by a microdilution susceptibility test using 96 well plates. A 50% dilution 
of conditioned media from 3 AFDC cultures and 3 MDC cultures was aliquoted into wells (90 uL) in triplicate. 
Subsequently, a bacterial suspension comprised of 10 µL of LB broth containing 100 CFUs was added to the CM. 
The plates were incubated for 8 h with constant shaking at 37 °C. Spectrophotometer readings were taken as opti-
cal densities (OD600). Values were expressed as percent O.D. relative to a control of cell-free DMEM and bacteria. 
The three wells corresponding to each dilution were combined, a 10 µL sample was removed from the composite, 
diluted serially, plated on LB agar, and incubated overnight at 37 °C for quantification of colony growth as colony 
forming units (CFU).
Viability assays. After 48 h of treatment with either liposaccharide (LPS) or alpha toxin (AT) in the presence 
of MDC CM, AFDC CM, or DMSO (control), a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) in vitro toxicology assay (Sigma-Aldrich) and lactate dehydrogenase (LDH) assay (Sigma-Aldrich) were 
carried out as per manufacturer’s instructions and absorbance was measured at 570 nm or 490 nm respectively on 
a Multiskan EX plate reader (ThermoFisher Scientific). Values were expressed relative to untreated wells.
Bromodeoxyuridine proliferation assay. The effect of CM on the proliferation of MDBK and BLMVEC 
was evaluated using a bromodeoxyuridine (BrdU) proliferation assay kit (Abcam). Cells were seeded on a 96 
well plate at a density of 4 × 104 cells per well and incubated with unconditioned medium (control), MDC CM, 
or AFDC CM for 48 h. The BrdU proliferation assay kit was used according to the manufacturer’s instructions 
and the resulting absorbance was read at 450 nm using a Multiskan EX microplate reader and Ascent software 
(ThermoFisher Scientific). Empty wells and wells without BrdU were included as controls.
Angiogenesis Assay. Endothelial tube-like formation assays were performed using an in vitro angiogenesis 
assay kit, according to the manufacturer’s instructions (Cayman Chemicals, Ann Arbor, MI). BLMVEC were 
seeded in triplicate onto an extracellular matrix gel (1 × 104 cells per well) and incubated in 100 µl of either MDC 
or AFDC CM or DMEM to establish the baseline BLMVEC growth or 1 μM JNJ-10198490 was used as a negative 
control, according to the manufacturer’s instructions. After 18 h of culture, the BLMVEC were stained with 10 μl 
of 10X cell-based calcein (Cayman Chemicals) and the presence of tree-like tubular networks was examined using 
a ZOE Fluorescent Cell Imager (BioRad).
In vitro scratch assay. Scratch assays were carried out as previously described45. MDBK cells were seeded 
at 8,000 cells/cm2. After 24 h, a line in the monolayer was performed with a sterile p200 pipette tip and medium 
was changed to DMEM, MDC CM, or AFDC CM. Zero, 24, and 48 h post scratching images were captured using 
a Nikon Diaphot-TMD inverted light microscope with an attached Cohu CCD camera (Nikon, Melville, NY). 
Image J software (http://rsbweb.nih.gove/ij/) was used to measure the distance of the scratch.
Recombinant Proteins and Neutralizing Antibodies. The recombinant proteins used in the present 
study include bovine TGFβ (1916 pg/ml), (LifeSpan Biosciences, Inc., WA), bovine IGF-1 (82 pg/ml) and human 
HGF (57 pg/ml; ThermoFisher Scientific). The neutralizing antibodies used in the present study include TGFβ 
(MM0446-6G14), IGF-1 (SPM406), and HGF (MM0326-5D20) from Novus Biologicals (Littleton, CO) at a con-
centration of 50 times the amount reported by ELISA.
Statistical analyses. The Student’s t test for unpaired data was used to evaluate differences between the 
means when comparing MDC to AFDC (cells or CM) for the following analyses: percentage of expression in flow 
cytometry, band intensity in Western blot analyses, protein quantifications in ELISAs, viability assays analyses, 
BrdU analyses, and migration assays. One-way ANOVA, followed by the Tukey’s multiple comparison test, was 
Gene Product Abbreviation Forward Sequence (5′ → 3′) Reverse Sequence (5′ → 3′)
Fms related tyrosine kinase 1 FLT1 AACACAAGAGTTGAGATGACCTG TGACAATCAGAGTGACAGTGAAG
TEK receptor tyrosine kinase TEK CTGTTAATCACTATGAGGCTTGG TAAAAGTCATCTTCTGAGCTTGG
Transforming growth factor beta receptor TGFBR GACCAGTCTGCTTTGTCTGTATC GTCTGATAAATCTCTGCTTCACG
Insulin-like growth factor receptor IGFR TTACTCTGTACCGAATCGACATC TTATAACCAAGCCTCCCACTATC
MET proto-oncogene, receptor tyrosine 
kinase MET ATGGTAATAAATGTGCATGAAGC ACAATCAATCCTGTGAAATTCTG
Table 3. Primers used for gene expression analyses.
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used to assess differences in migration rates between recombinant proteins, neutralizing antibodies, stimulated 
CM, and frozen CM. Where not specified, a value of P < 0.05 was considered statistically significant. GraphPad 
software was used for analysis (GraphPad Software, La Jolla, CA, USA). Data given are the mean of three repli-
cates and the bars show standard deviation.
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